CMMB - TLRY ET ROKU and NET among premarket gainers

iBio (IBIO) +33% on COVID-19 study update.Orgenesis (ORGS) +11% on Q1 results.Chemomab Therapeutics (CMMB) +12%.T2 Biosystems, Inc. (TTOO) +11% on Q1 results.ViewRay (VRAY) +12%.Epizyme (EPZM) +11% on Q1 results.CureVac N.V. (CVAC) +9%.Roku (ROKU) +9% on Q1 results.Datadog (DDOG) +9% on Q1 results.GoPro (GPRO) +9% on Q1 results.Tilray (TLRY) +8%.BioNTech SE (BNTX) +7%.Evofem Biosciences (EVFM) +7% on Q1 results.So-Young International (SY) +6% as it refutes Blue Orca Capital’s report and announces buyback plan.Peloton Interactive (PTON) +6% as Needham keeps a Buy rating on Peloton.Regional Health Properties (RHE) +4%.Cloudflare (NET) +6% on Q1 results.Fulgent Genetics (FLGT) +5% on Q1 results.VYNE Therapeutics (VYNE) +5% on Q1 results.Cyclerion Therapeutics (CYCN) +5%.Energy Transfer LP (ET) +5% on Q1 results.

For further details see:

TLRY, ET, ROKU and NET among premarket gainers